Login / Signup

SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments.

Xinyi WangJingwen LiHanshu LiuXinyu HuZhicheng LinNian Xiong
Published in: Microorganisms (2023)
For three years, the novel coronavirus disease 2019 (COVID-19) pandemic, caused by infection of the SARS-CoV-2 virus, has completely changed our lifestyles and prepared us to live with this novel pneumonia for years to come. Given that pre-existing flu is caused by the influenza A virus, we have begun unprecedently co-coping with two different respiratory diseases at the same time. Hence, we draw a comparison between SARS-CoV-2 and influenza A virus based on the general characteristics, especially the main variants' history and the distribution of the two viruses. SARS-CoV-2 appeared to mutate more frequently and independently of locations than the influenza A virus. Furthermore, we reviewed present clinical trials on combined management against COVID-19 and influenza in order to explore better solutions against both at the same time.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • clinical trial
  • social support
  • community acquired pneumonia